![Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_JFP_06407_ArticleW1_t2.jpg.jpg)
Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine
![Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis | Request PDF Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis | Request PDF](https://i1.rgstatic.net/publication/324361740_Light_chain_monoclonal_gammopathy_of_undetermined_significance_is_characterized_by_a_high_disappearance_rate_and_low_risk_of_progression_on_longitudinal_analysis/links/5fb7182192851c933f42a698/largepreview.png)
Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis | Request PDF
![Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML](https://www.mdpi.com/cancers/cancers-12-01554/article_deploy/html/images/cancers-12-01554-g001.png)
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
![Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrneph.2009.151/MediaObjects/41581_2009_Article_BFnrneph2009151_Fig1_HTML.jpg)
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
![Monoclonal Gammopathies of Undetermined Significance (MGUS): Practice Essentials, Pathophysiology, Epidemiology Monoclonal Gammopathies of Undetermined Significance (MGUS): Practice Essentials, Pathophysiology, Epidemiology](https://img.medscapestatic.com/thumbnail_library/920799.jpg)
Monoclonal Gammopathies of Undetermined Significance (MGUS): Practice Essentials, Pathophysiology, Epidemiology
![Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study - The Lancet Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/ba3ef165-f300-41a4-abc0-206eb55e7d2b/gr1_lrg.jpg)
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study - The Lancet
![Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-019-0210-z/MediaObjects/41408_2019_210_Fig1_HTML.png)